Back to calendar
Fate Therapeutics, Inc. (FATE) Earnings
FATE reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.27
Actual EPS: $-0.25
Company overview
Market Cap$286.4M
SectorHealth Technology
IndustryBiotechnology